Tüdőrák: vizsgálatok itt: Hollandia
141 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 3. fázisNot yet taking people in HollandiaClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Where
- Arnhem, Maastricht
- Életkor
- 18 év and over
- People
- 780 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT06767514 · EU 2024-518629-14-00 - 3. fázisTaking peoplePhase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
- Where
- Amsterdam, Nijmegen, Rotterdam, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- Amgen Inc.
See details and how to join2026-525489-23-00 - 1/2. fázisTaking peopleStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00 - No phaseTaking peopleRegistry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Mark C Burgmans, MD PhD
See details and how to joinNCT07636148 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Amsterdam, Heerlen, Leeuwarden, Maastricht, Nieuwegein
- Életkor
- 18 év and over
- People
- 355 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2024-515884-69-00 - No phaseTaking peopleIrreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 27
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT07782164 - 1. fázisTaking peopleA Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
- Where
- Groningen
- Életkor
- 18 év to 100 év
- People
- 36
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07117214 - 3. fázisNot yet taking people in HollandiaDoes a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 426 worldwide
- Run by
- Norges Teknisk-Naturvitenskapelige Universitet NTNU
See details and how to join2026-525513-31-00 - 4. fázisTaking peopleChemoradiotherapy With Surgery Followed by Consolidation Durvalumab
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 38
- Run by
- Idris Bahce
See details and how to joinNCT06908070 - 1/2. fázisBefejeződöttA Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 15
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT05701176 · EU 2024-517960-45-00 - 2/3. fázisBefejeződöttAssessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 34
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06457789 · EU 2023-509486-20-00 - 1. fázisTaking peopleA Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours
- Where
- Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Deuteroncology
See details and how to join2023-504897-39-00 - 1. fázisTaking peopleA phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 36
- Run by
- Novartis Pharma AG
See details and how to join2024-517746-34-00 - 3. fázisFut, nem toborozStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Groningen, Maastricht, Rotterdam
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 - 2. fázisTaking peopleWhole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 16
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06222489 · EU 2023-508233-14-00 - 3. fázisTaking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Maastricht, 's-Hertogenbosch, Tilburg
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Nijmegen, Utrecht
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - 3. fázisNot yet taking people in HollandiaPhase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Where
- Arnhem, Rotterdam, 's-Hertogenbosch, Zwolle
- Életkor
- 18 év and over
- People
- 756 worldwide
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583 - No phaseTaking peopleNovel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
- Where
- Amsterdam
- People
- 100
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07511933 - 2. fázisNot yet taking people in HollandiaPhase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Amsterdam, Groningen
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 3. fázisFut, nem toborozA Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy
- Where
- Arnhem, Rotterdam, Zwolle
- Életkor
- 18 év and over
- People
- 147 worldwide
- Run by
- Shanghai Junshi Biosciences Co. Ltd.
See details and how to join2023-507097-41-01